BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35132492)

  • 1. Association between extract of Euphorbia szovitsii and expression level of microRNAs in MDA-MB-231 cell line.
    Asadi-Samani M; Mahmoudian-Sani MR
    Mol Biol Rep; 2022 May; 49(5):3531-3537. PubMed ID: 35132492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of
    Asadi-Samani M; Rafieian-Kopaei M; Lorigooini Z; Shirzad H
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30459240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of MicroRNAs by
    Mahmoudian-Sani MR; Asadi-Samani M
    Recent Pat Anticancer Drug Discov; 2020; 15(2):174-184. PubMed ID: 32603285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
    Shuaib M; Chaudhri S; Kumar S
    Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets
    Hajalirezay Yazdi S; Paryan M; Mohammadi-Yeganeh S
    Cell Mol Biol Lett; 2018; 23():51. PubMed ID: 30386383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a.
    Coppola A; Ilisso CP; Stellavato A; Schiraldi C; Caraglia M; Mosca L; Cacciapuoti G; Porcelli M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
    Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
    BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
    Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
    Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
    Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
    J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
    Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
    Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200c/PAI-2 promotes the progression of triple negative breast cancer via M1/M2 polarization induction of macrophage.
    Meng Z; Zhang R; Wang Y; Zhu G; Jin T; Li C; Zhang S
    Int Immunopharmacol; 2020 Apr; 81():106028. PubMed ID: 31801690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
    Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
    Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico analysis of the association of hsa-miR-16 expression and cell survival in MDA-MB-231 breast cancer cells subjected to photodynamic therapy.
    Cupido-Sánchez MG; Herrera-González NE; Mendoza CCB; Hernández MLM; Ramón-Gallegos E
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102106. PubMed ID: 33217568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.